摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-hydroxy-2-(4-(methylthio)phenyl)-4H-chromen-4-one

中文名称
——
中文别名
——
英文名称
7-hydroxy-2-(4-(methylthio)phenyl)-4H-chromen-4-one
英文别名
7-Hydroxy-2-(4-methylsulfanylphenyl)chromen-4-one
7-hydroxy-2-(4-(methylthio)phenyl)-4H-chromen-4-one化学式
CAS
——
化学式
C16H12O3S
mdl
——
分子量
284.335
InChiKey
BDLWYGWQYIDDSM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    71.8
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    4-(2-氯-1-亚氨基乙基)苯-1,3-二醇 在 盐酸 、 sodium hydroxide 作用下, 以 乙醇 为溶剂, 生成 7-hydroxy-2-(4-(methylthio)phenyl)-4H-chromen-4-one
    参考文献:
    名称:
    Inhibitory effect of flavonoids on human glutaminyl cyclase
    摘要:
    Glutaminyl cyclase (QC) plays an important role in the pathogenesis of Alzheimer's disease (AD) and can be a potential target for the development of novel anti-AD agents. However, the study of QC inhibitors are still less. Here, phenol-4' (R1-), C5-OH (R2-) and C7-OH (R3-) modified apigenin derivatives were synthesized as a new class of human QC (hQC) inhibitors. The efficacy investigation of these compounds was performed by spectrophotometric assessment and the structure-activity relationship (SAR) was evaluated. Molecular docking was also carried out to analyze the binding mode of the synthesized flavonoid to the active site of hQC. (C) 2016 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2016.03.064
点击查看最新优质反应信息

文献信息

  • Inhibitory effect of flavonoids on human glutaminyl cyclase
    作者:Manman Li、Yao Dong、Xi Yu、Yongdong Zou、Yizhi Zheng、Xianzhang Bu、Junmin Quan、Zhendan He、Haiqiang Wu
    DOI:10.1016/j.bmc.2016.03.064
    日期:2016.5
    Glutaminyl cyclase (QC) plays an important role in the pathogenesis of Alzheimer's disease (AD) and can be a potential target for the development of novel anti-AD agents. However, the study of QC inhibitors are still less. Here, phenol-4' (R1-), C5-OH (R2-) and C7-OH (R3-) modified apigenin derivatives were synthesized as a new class of human QC (hQC) inhibitors. The efficacy investigation of these compounds was performed by spectrophotometric assessment and the structure-activity relationship (SAR) was evaluated. Molecular docking was also carried out to analyze the binding mode of the synthesized flavonoid to the active site of hQC. (C) 2016 Elsevier Ltd. All rights reserved.
查看更多